Related Experiment Video
Updated: Jun 4, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician
Tiago L L Leiria1, Renato D Lopes, Judson B Williams
1Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, Brazil.
Insights
Patients with prosthetic heart valves need long-term blood thinners. This review covers guidelines for oral anticoagulation, balancing risks of clots and bleeding with vitamin K antagonists.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Patients with prosthetic heart valves require lifelong oral anticoagulation therapy.
- Managing anticoagulation involves balancing thromboembolic and bleeding risks.
Purpose of the Study:
- To review current major heart valve guidelines.
- To focus on oral anticoagulation strategies for patients with prosthetic heart valves.
Main Methods:
- Literature review of existing clinical guidelines.
- Analysis of recommendations for oral anticoagulation in prosthetic heart valve patients.
Main Results:
- Vitamin K antagonists are currently the only approved oral anticoagulants for this indication.
- Guidelines emphasize careful monitoring to manage risks.
Conclusions:
- Oral anticoagulation is essential for patients with prosthetic heart valves.
- Adherence to guidelines is crucial for optimizing therapy and patient outcomes.
Abstract:
Patients with prosthetic heart valves require chronic oral anticoagulation. In this clinical scenario, physicians must be mindful of the thromboembolic and bleeding risks related to chronic anticoagulant therapy. Currently, only vitamin K antagonists are approved for this indication. This paper reviews the main heart valve guidelines focusing on the use of oral anticoagulation in these patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Rheumatic Heart Disease III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Endocarditis III: Medical Management
